Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1655, 2008-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Disheartening results for pexelizumab in acute STEMI
Inpharma, Vol. 1, Iss. 1570, 2007-01 ,pp. :
Bivalirudin brings benefit to treatment of STEMI
Inpharma, Vol. 1, Iss. 1661, 2008-01 ,pp. :
SY 161-P5 as effective as alteplase in acute STEMI
Inpharma, Vol. 1, Iss. 1413, 2003-01 ,pp. :